THE SCHEDULE 13D

Company

Sensei Biotherapeutics, Inc.

Filed

July 19, 2022

Accession Number

0001193805-22-001110

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →